info@seagull-health.com
SeagullHealth
语言:
search
new
How to buy Quizartinib
502
Article source: Seagull Pharmacy
Jul 15, 2025

Quizartinib is a therapeutic drug for specific leukemia. Its purchase channels, specifications, properties and indications are the focus of patients and their families. This article will focus on these three aspects to provide patients with comprehensive and concise information.

How to buy Quizartinib

For patients who need this drug, the following channels can be considered.

Overseas purchase

Patients can choose to go to hospital pharmacies or regular pharmacies in countries or regions where Quizartinib has been launched for consultation and purchase. Since the price of the drug may be affected by regional differences, exchange rate changes and other factors, patients need to make budgets and plans before purchase.

Purchase by medical service institutions

Patients can consult domestic overseas medical service institutions that cooperate with international pharmacies or pharmaceutical companies. These institutions can usually provide legal import channels and can provide professional consultation and guidance.

When purchasing Quizartinib, patients and their families should fully understand the drug information, choose regular channels, and pay attention to relevant domestic and foreign policies and legal changes in order to adjust the purchase strategy in time.

Specifications and properties of Quizartinib

The specifications and properties of Quizartinib are very important for patients to use the drug. Knowing this information will help patients use the drug correctly.

Various specifications

Quizatinib has a variety of specifications, such as 17.7mg. Different specifications of drugs may have differences in dosage and usage. Patients need to use them correctly according to the doctor's prescription and drug instructions.

Properties

Quizatinib is a white film-coated tablet. This characteristic helps patients identify the authenticity of the drug. Before taking the drug, patients should carefully check the drug packaging and appearance.

Storage requirements

Quizatinib needs to be sealed and stored at room temperature to help the stability and effectiveness of the drug. Patients should store the drug in a dry and cool place, avoiding direct sunlight and high temperature environment.

Understanding the specifications of quizatinib will help patients use and store the drug correctly. Patients need to follow the doctor's prescription and drug instructions and use the drug rationally.

Quizatinib indications

Quizatinib is mainly used to treat specific types of leukemia, and its indications are clear and targeted.

Targeting FLT3-ITD mutation-positive AML

Quizatinib is mainly used to treat relapsed or refractory FLT3-ITD mutation-positive acute myeloid leukemia (AML). This indication makes quizatinib an important treatment option for patients with this type of leukemia.

Clear pharmacological action

Quizatinib exerts its therapeutic effect by inhibiting FLT3 activity. FLT3 is one of the common mutated genes in AML, and its abnormal activation can lead to leukemia cell proliferation and survival. Quizatinib can specifically inhibit FLT3 activity, thereby inhibiting the growth and spread of leukemia cells.

Quizatinib is an effective drug for the treatment of FLT3-ITD mutation-positive AML, with clear indications, clear pharmacological effects and good effects. Patients should use this drug reasonably under the guidance of a doctor in order to obtain the best therapeutic effect.

Note: For internal discussion among medical personnel only. For specific medication, please consult the attending physician. Drug information may change over time. For the latest information, we recommend adding a medical consultant or consulting for free online.
Quizartinib(VANFLYTA)
Quizartinib(VANFLYTA)
VANFLYTA is indicated for adult patients with newly diagnosed Acute Myeloid...
WeChat Scan
Free Inquiry
Recommended Articles
How much is a box of Quizartinib?
Quizartinib is a drug for the treatment of specific leukemia, which has attracted much attention from the medical community and patients. Its price varies depending on the manufacturer, specifica...
What are the adverse reactions of rivastigmine transdermal patch?
Rivastigmine transdermal patch is a drug used to treat Alzheimer's disease and Parkinson's disease dementia. It has significant efficacy, but it also has certain adverse reactions. It is very ...
What are the side effects of rivastigmine?
Rivastigmine is a drug used to treat Alzheimer's and Parkinson's dementia. It has significant efficacy, but it is also accompanied by a series of possible side effects. One of the common side ...
What is Rivastigmine?
Rivastigmine, developed by Novartis, is an innovative drug for the treatment of Alzheimer's and Parkinson's dementia. Rivastigmine is administered in the form of a transdermal patch, providing...
Indications of Quizartinib
Quizartinib is a targeted therapy for acute myeloid leukemia caused by specific gene mutations. It is mainly used to treat relapsed or refractory FLT3-ITD mutation-positive AML and works by inhib...
Quizartinib instructions, medical insurance, price, efficacy, side effects
Quizartinib is a drug for the treatment of specific leukemias, which has attracted widespread attention in the international medical field. This article will conduct an in-depth discussion on the...
How to use Quizartinib
Quizartinib is a therapeutic drug for patients with specific acute myeloid leukemia (AML). This article aims to introduce in detail the use of Quizartinib, drug interactions and precautions for s...
How effective is Quizartinib(Vanflyta)?
Quizartinib (Vanflyta) is a targeted therapy for FLT3 mutation-positive acute myeloid leukemia (AML). It has excellent therapeutic effects and is highly concerned by patients. The following is a ...
Related Articles
Side Effects of Quizartinib
Quizartinib is an oral kinase inhibitor primarily indicated for the treatment of newly diagnosed FLT3-ITD-positive acute myeloid leukemia (AML). As a targeted therapy, it offers therapeutic efficacy a...
What are the precautions for taking Quizartinib?
Quizartinib is a selective FLT3 kinase inhibitor indicated for the treatment of adult patients with newly diagnosed FLT3-ITD positive acute myeloid leukemia (AML). When used in combination with standa...
Dosage and Administration of Quizartinib
Quizartinib is a kinase inhibitor targeting the FLT3 receptor, which was first approved in the United States in 2023. In combination with standard induction therapy using cytarabine and anthracyclines...
What are the Indications of Quizartinib?
Quizartinib is an innovative kinase inhibitor that received its first approval in the United States in 2023.What are the Indications of Quizartinib?Primary Therapeutic AreaQuizartinib is a kinase inhi...
What Are the Purchase Channels for Quizartinib?
Quizartinib is a kinase inhibitor indicated for adult patients with newly diagnosed acute myeloid leukemia (AML) who have been confirmed to carry the FLT3 internal tandem duplication (FLT3-ITD) mutati...
Precautions when taking Quizartinib
Quizartinib (Vanflyta) is indicated for the treatment of newly diagnosed adult patients with acute myeloid disease (AML) who are positive for FLT3 internal tandem duplication (ITD) as detected by...
Side effects of Quizartinib
Quizartinib is a targeted therapy for FLT3 mutation-positive acute myeloid leukemia, which has shown certain efficacy in clinical applications. Its use is also accompanied by a series of side eff...
How effective is Quizartinib(Vanflyta)?
Quizartinib (Vanflyta) is a targeted therapy for FLT3 mutation-positive acute myeloid leukemia (AML). It has excellent therapeutic effects and is highly concerned by patients. The following is a ...
New Drugs
Infigratinib(Truseltiq)
Infigratinib(Truseltiq)
Treatment of previously treated, unresectable locally advanced or metastatic...
Opicapone(Ongentys)
Opicapone(Ongentys)
Adjunctive treatment to levodopa/carbidopa for reducing "off" episodes in...
Deflazacort(Emflaza)
Deflazacort(Emflaza)
Treatment of Duchenne muscular dystrophy (DMD) in patients aged 2 years and...
Faricimab-svoa(Vabysmo)
Faricimab-svoa(Vabysmo)
Treatment of neovascular age-related macular degeneration, diabetic macular...
Counselling Service
Global Drug Search
Clinical Research Recruitment
Overseas Medical Treatment
Remote Consultations
Note: Our medical consultant will contact you as soon as possible. We promise to strictly protect your privacy.
Submit
Business
  • Core products
  • Antitumor drugs
  • General drug
  • Antiviral drugs
  • Biological agents
Contact Us 
  • mailbox:info@lucius.la
Welcome to consult
ucius Pharmaceuticals (Lao) Co.,Ltd All rights reserved